First, some excellent reviews explaining some key preliminaries of FMs:
🔍 self-supervised learning:
a paradigm that allows for the training of AI models w/o explicit and costly labels (huge for medical applications). nature.com/articles/s4155…
(2/9)
🔍 multimodal AI:
Medicine is driven by various types of data that hold complementary information. The rise of multimodal medical AI promises holistic views on patients and their diseases. nature.com/articles/s4159…
(3/9)
FMs in medicine can be divided into two groups:
A) domain-specific models, i.e. developed for the medical domain, and
B) general-domain models that are adapted to the biomedical domain.
Next a few excellent examples (all from 2022!) for both categories:
(4/9)
🩺 A) Domain-specific models
ChexZero: a self-supervised model that achieved expert-level classification of pathologies in chest X-rays w/o being trained on explicit labels nature.com/articles/s4155…
(5/9)
Dragon: a combined language-knowledge graph model that can perform advanced medical reasoning tasks. arxiv.org/pdf/2210.09338…
(6/9)
✨B) General-domain models adapted to medical domain:
RoentGen: a vision-language model for generating chest X-rays w/ pathologies based on text prompts (based on Stable Diffusion). arxiv.org/pdf/2211.12737…
(7/9)
Med-PaLM: a 540B-parameter language model was adapted to medical domain via instruction prompt tuning. Current state of the art with ~67% on USMLE questions (MedQA dataset), one of the first approaches with a passing score. arxiv.org/pdf/2212.13138…
(8/9)
These papers are just a snapshot of the progress being made, though big challenges (like biases) are far from addressed. Also, it may still take some time until we see actual patient benefit from these developments.
Excited to see what 2023 will bring!
(9/9)
If you want to predict clinical phenotypes using #MachineLearning, check out our systematic review on ML-based #sepsis prediction. A THREAD with take-aways that could be relevant to #AI in #healthcare in general. (--> = hints for practitioner) 1/n bit.ly/34pIvRs
1) Motivation: why should we even care about #sepsis? For decades clinicians have a) struggled to detect it in its early stages where organ damage is still reversible and b) failed to find a robust and early biomarker for sepsis. 2/n
--> Make sure that your problem (as well as your solution) *actually matters* (e.g., how is it helping doctors if you just foresee that a patient won't make it?) and ensure that it cannot be easily solved by conventional approaches.
3/n